Dartmouth-Hitchcock Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Dartmouth-Hitchcock Medical Center sits in the top decile of US sponsors by registered trial count (#85 of 15,742 sponsors by registered trial count).
Dartmouth-Hitchcock Medical Center: 427 sponsored US clinical trials, 52 recruiting.
Dartmouth-Hitchcock Medical Center sponsors 427 registered US clinical trials on ClinicalTrials.gov, 52 of them currently recruiting, and 300 completed. 25 of these trials are in Phase 3-4 (later-stage) and 84 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 12 trials.
Top-decile sponsor footprint
Dartmouth-Hitchcock Medical Center ranks in the top decile of sponsors by registered trial count (#85 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
300 of 352 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
427 total, page 6 of 9
Using Web-based Tools to Facilitate Tailored Exercise for People With Osteoarthritis
NCT02404974
Using The HOPES Program in Transition Care
NCT02420340
Electrical Activity of Diaphragm as a Means to Predict Extubation Success in Preterm Infants
NCT02144363
Vascular Physician Offer and Report (VAPOR) Trial
NCT02220686
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
NCT01964404
Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment
NCT02188758
Study of Promethazine for Treatment of Diabetic Gastroparesis
NCT02130622
ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
NCT01984268
A Randomized, Controlled Trial to Determine the Effects of an Exercise Intervention on Physical Activity During Chemotherapy for Patients With Early Stage Breast Cancer
NCT02159157
Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM)
NCT02071056
Secretin Infusion to Prevent Pancreatic Leaks Following Pancreatic Resection
NCT02160808
Randomized Controlled Trial (RCT) of a Motivational Decision Support System
NCT02086162
Evaluation of Inhaled Antibiotics on Bacterial Diversity and Richness in the Cystic Fibrosis Lung
NCT02113397
Evaluating a Shared Decision Making Program for Crohn's Disease
NCT02084290
Imaging Neuroinflammation in Epilepsy With Ferumoxytol MRI
NCT02084303
Phase I Trial of DAR-901
NCT02063555
Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.
NCT02010021
Incentives, Cognitive Training and Internet Therapy for Teens With Poorly Controlled Type 1 Diabetes
NCT01722643
Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy
NCT02139280
Patient Derived Breast Cancer Xenografts
NCT01750164
Developing Plasma DNA as a Surrogate for Tumor Biopsy to Identify Tumor Genetic Alterations in Patients With Advanced Breast Cancer
NCT01836640
Evaluating Instrumentation for Dental Devices Used in Treating Sleep Apnea
NCT02056327
Behavioral Treatment of Adolescent Substance Use
NCT02063984
Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
NCT01849952
Hand Hygiene and Hospital Acquired Infections
NCT02252562
Hyperbaric Oxygen for Ulcerative Colitis
NCT02144350
A Proof-of-principle Study of HBO-SRS for Brain Metastases
NCT01850563
Differentiating the Effects of Substance P and Beta-endorphin
NCT01854177
Clozapine for Cannabis Use in Schizophrenia
NCT01639872
BR in Patients With CLL With Comorbidities and/or Renal Dysfunction
NCT01832922
Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders
NCT01834794
Reducing Disability in Older Adult Cancer Survivors
NCT01709344
Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness
NCT01779440
Rectal Indomethacin to Prevent Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis
NCT01774604
Effect of a Goal Setting Intervention on Exercise in Women With Metastatic Breast Cancer: An Exploration of The Lipogenic Pathway
NCT01653366
OPERA Database - Crohn's Protocol
NCT01720368
IBD-OPERA Database, UC Protocol
NCT01708395
Tumor Specific Plasma DNA
NCT01617915
A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL)
NCT01463852
Fluoroscopy-guided Versus Traditional Placement of Epidural Catheters
NCT02678039
A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection
NCT01645852
New Hampshire Medicaid Wellness Incentive Program
NCT02515981
The Role of Substance P on Perception of Breathlessness During Resistive Load Breathing
NCT01580423
Risperidone and Desipramine in Alcohol Use and Schizophrenia
NCT01411085
Do Oral Steroid Dose Packs Predict How Well Epidural Steroid Injections Will Work?
NCT02026726
Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment
NCT01460914
Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia
NCT01460238
Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach
NCT01792765
Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial
NCT01583400
Reduction in IV Associated Contamination
NCT01426217
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 44 |
| Phase 2 | 40 |
| Phase 3 | 6 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the Dartmouth-Hitchcock Medical Center pipeline
52 recruiting of 427 indexed (12% open); 300 completed (70%).
Phase mix: 25 late (III/IV) vs 84 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Dartmouth-Hitchcock Medical Center: open-pipeline peers nationwide
Peers matched on 427 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
Dartmouth-Hitchcock Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 427 trials (± recruiting share)
- University of Illinois at Chicago · 430 trials · 27% recruiting
- Vanderbilt University · 430 trials · 3% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Friends Research Institute · 12% recruiting · 41 trials
- Antonios Likourezos · 12% recruiting · 33 trials
- Oregon State University · 12% recruiting · 33 trials
- University of Massachusetts, Amherst · 12% recruiting · 33 trials
Related
What to do with this Dartmouth-Hitchcock Medical Center page
427 registered trials is a research-attention snapshot, not an endorsement of Dartmouth-Hitchcock Medical Center or any single study.
- 52 of Dartmouth-Hitchcock Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Dartmouth-Hitchcock Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Dartmouth-Hitchcock Medical Center pipeline card: 427 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.